Megakaryocyte maturation is associated with expression of the CXC chemokine connective tissue-activating peptide CTAP III

British Journal of Haematology

Volumn 111, Issue 4, 2000, Pages 1180-1189

  Deutsch, Varda ^a,b   Bitan, Menachem ^b   Friedmann, Yael ^b   Eldor, Amiram ^a   Vlodavsky, Israel ^b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

CTAP III; CXC chemokine; Differentiation; Maturation; Megakaryocytes

Indexed keywords

ALPHA CHEMOKINE; BETA THROMBOGLOBULIN; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE;

ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MEGAKARYOBLAST; MEGAKARYOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BLOOD COAGULATION FACTORS; BLOOD PLATELETS; BONE MARROW CELLS; CELL COUNT; CELL DIFFERENTIATION; CELL LINE; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKEMIA, MYELOID, CHRONIC; MEGAKARYOCYTES; MODELS, BIOLOGICAL; PEPTIDES; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TETRADECANOYLPHORBOL ACETATE;

EID: 0034490258     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.02476.x     Document Type: Article

References (43)

1. In vivo effect of platelet factor 4 and tetrapeptide mAcSDKP on hematopoiesis of mice treated with 5 fluorouracil
2. Relationship of one form of human histamine-releasing factor to connective tissue activating peptide-III
3. CC chemokines in allergic inflammation
4. Structural and biological characteristics of connective tissue activating peptide (CTAP-III): A major platelet derived growth factor
5. Relationship of one form of human histamine-releasing factor to connective tissue activating peptide-III
6. Connective tissue activation XXXIV. Effects of proteolytic processing on the biological activities of CTAP III
7. Connective tissue activation XXXV. Detection of CTAP-III isoforms in synovium of osteoarthritis and rheumatoid arthritis patients, patterns of interaction with other synovial cytokines in cell culture
8. Connective tissue activation XXXVI. The origin, variety, distribution and biological fate of CTAP III isoforms: Characteristics in patient with rheumatic, renal and arterial disease
9. Stem cell factor (SCF) synergizes with megakaryocyte colony stimulating activity in post-irradiated aplastic plasma in stimulating human megakaryocytopoiesis
10. Quantitation of changes in the expression of multiple genes by simultaneous polymerase chain reaction
11. Megakaryocyte interaction with the subendothelial extracellular matrix
12. Inhibition of human megakaryocytopoiesis in vitro by platelet factor 4 (PF4) and a synthetic COOH-terminal PF4 peptide
13. Chemokine regulation of human megakaryocytopoiesis
14. Interplay of T cells and cytokines in the context of enzymatically modified extracellular matrix
15. Negative regulation of human megakaryocytopoiesis by human platelet factor 4 and connective tissue activating peptide III (CTAP III)
16. Platelet factor 4 inhibits human megakaryocytopoiesis in vitro
17. Negative regulation of human megakaryocytopoiesis by human platelet factor 4 and beta thromboglobulin: Comparative analysis in bone marrow culture from normal individuals and patients with essential thrombocythaemia and immune thrombocytopenic purpura
18. In vivo inhibition of megakaryocyte and platelet production by platelet factor 4 in mice
19. Platelet factor 4 and CXC chemokines support the survival of normal hematopoietic cells and reduce the chemosensitivity of cells to cytotoxic agents
20. CXC chemokines connective tissue activating peptide III and neutrophil activating peptide 2 are heparin/heparan sulfate degrading enzymes
21. Chemokines: Progress toward identifying molecular targets for therapeutic agents
22. Leukocyte derived growth factor links the PDGF and CXC chemokine family of peptides
23. Heparanase activity expressed by platelets, neutrophils and lymphoma cells releases active fibroblast growth factor from extracellular matrix
24. Carboxy-terminal peptides (C1-24 and C13-24) but not (C1-13) of platelet factor 4 inhibit murine megakaryocytopoiesis, an activity which is neutralized by heparin
25. Megakaryocyte interaction with subendothelial extracellular matrix is associated with adhesion, platelet like shape change and thromboxane A production
26. Immature human megakaryocytes produce nuclear-associated acetylcholinesterase
27. Chemokines regulate T cell adherence to recombinant adhesion molecules and extracellular matrix proteins
28. Characterization of the human beta-thromboglobulin gene. Comparison with the gene for platelet factor 4
29. Chemokines
30. Properties of the novel proinflammatory supergene "intercrine" cytokine family
31. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4
32. Chemokine and Chemokine receptor m-RNA expression in human platelets
33. A cellulose-binding domain-fused recombinant human T cell connective tissue activating peptide III manifests heparanse activity
34. Chemokines
35. Lipopolysaccharide stimulated human monocytes secrete apart from neutrophil activating peptide 1/interleukin 8, a second neutrophil activating protein
36. Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes
37. Endothelial cell derived basic fibroblast growth factor, synthesis and deposition into the extracellular matrix
38. Extracellular matrix bound growth factors, enzymes and plasma proteins
39. Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis
40. Effects of NAP-2, platelet basic protein, CTAP III and platelet factor 4 on neutrophils
41. Cloning of cDNA coding for connective tissue activating peptide III from a human platelet derived ggtll expression library
42. The urokinase receptor (CD87) is expressed in cells of the megakaryocyte lineage
43. + cord blood cells, comparative studies with transforming growth factor beta